” While the Ricaurte story was unfolding, MAPS lastly obtained FDA signal-off with a protocol for human trials of MDMA to be a therapy for PTSD, but only immediately after it procured a $one million insurance policy to indemnify the review board.The target provided ecstasy to cost-free-kick aficionados, that have experienced minimal to cherish at